The role of CEO is, subordinate to the Board of Directors and its main task is to carry out the daily management of Xbrane and the daily activities of the Company. The Board of Director’s rules of procedure and instructions for the CEO stipulate for which matters the Board of Directors is responsible to decide upon, and which decisions fall within the CEO’s area of responsibility. The CEO is also responsible for producing reports and necessary data for decision-making ahead of Board meetings and for presenting the material at Board meetings.

Xbrane has a management team consisting of six people, which in addition to the CEO is comprised of the COO/Head of Biosimilars, CFO/Head of IR, CTO, Head of Manufacturing and Supply Chain and Head of Clinical Affairs.

Management Team


Martin Åmark

Since 2015

Martin Åmark holds a M Sc. in industrial engineering and management from Linköping Institute of Technology and a MBA from INSEAD. He has 8 years of experience from Bain & Co as a management consultant. At Bain Martin worked mainly with M&A, strategy and organisation with Nordic clients across multiple industries, including life science and pharmaceuticals.

Shares: 7,412,166

Warrants: 853,038

COO & Head of Biosimilars

Siavash Bashiri

Since 2015

Siavash Bashiri holds a M Sc. in Molecular Biotechnology from Uppsala University. His latest position was with Agilent Technologies where he was the head of sales in EMEA for one of Agilent Technologies’ products within the Genomics department. He also has great knowledge of the commercialization of biotech start-ups from previous experiences.

Shares: 4,157,752

Warrants: 727,425

CFO & Head of IR

Anette Lindqvist

Since 2021

Anette Lindqvist has a degree in Business Administration from Gothenburg University of Economics. She has more than 25 years’ experience from the Life Science sector having held a number of Senior Finance & Business roles such as Global Clinical Finance Director at AstraZeneca, Head of Business Control at Swedish Orphan Biovitrum, Global CFO, SVP Finance Getinge Infection Control & Global CFO Operations & Supply Chain Mölnlycke Healthcare.

Shares: 14,000


Dr. David Vikström

Since 2014

David Vikström is the CTO of Xbrane Bioscience. He has a Ph.D. in expression and targeting of proteins in E. coli. He joined Xbrane in 2010 and successfully developed new technologies and strains for vaccine candidates. He is currently heading the development of Xbrane’s new expression systems to be able to take the expression in E. coli to new levels.

Shares: 464,953

Warrants: 78,264

Head of Manufacturing and Supply Chain

Anders Wallström

Since 2019

Anders Wallström holds a M. Sc. in Biotechnology from Royal Institute of Technology in Stockholm. He has more than 20 years of experience from process development, manufacturing and validation at SOBI and Biovitrum. Furthermore, he has significant experience from coordinating contract manufacturers for commercial products for both small molecule and biotech products.

Shares: 187,825

Warrants: 31,311



Head of Clinical Affairs

Dina Jurman

Since 2017

Dina Jurman holds a M.Sc. in Biomedicine from Uppsala University and has previously worked as Director Clinical Operations at IRW Consulting AB as well as Clinical Operations Manager consultant at Amgen Sweden.

Shares: 420

NamePositionMember of the senior management sinceEmployed at the Company sinceHoldings in Xbrane - SharesHoldings in Xbrane - Warrants
Martin ÅmarkCEO201520154,912,166853,038
Siavash BashiriCOO/Head of Biosimilars201220124,157,752727,425
Anette LindqvistCFO/Head of IR2020202014,000-
David VikströmCTO20142014464,95378,264
Anders WallströmHead of Manufacturing and Supply Chain20202019187,82531,311
Dina JurmanHead of Clinical affairs20172017420-